Abbott is one of four leading CGM manufacturers, along with Dexcom, Medtronic, and Eversense, that use needle‐based enzyme electrodes to detect glucose, according to a review in Bioengineering and ...
Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback